Celldex Therapeutics to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable
September 23 2016 - 11:30AM
Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that
Anthony Marucci, Co-founder, President and Chief Executive Officer,
and Thomas Davis, M.D., Executive Vice President and Chief Medical
Officer, will participate in a fireside chat at the Leerink
Partners Rare Disease & Immuno-Oncology Roundtable on Thursday,
September 29, 2016 at 2:00 p.m. EDT in New York.
The live webcast will be available on the "Events &
Presentations" page of the "Investors & Media" section of the
Celldex website. A replay will be available for seven days
following the event.
About Celldex Therapeutics, Inc.
Celldex is developing targeted therapeutics to address
devastating diseases for which available treatments are inadequate.
Our pipeline is built from a proprietary portfolio of antibodies
and immunomodulators used alone and in strategic combinations to
create novel, disease-specific therapies that induce, enhance or
suppress the body's immune response. Visit www.celldex.com.
Contact
Sarah Cavanaugh
Vice President of Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3161
scavanaugh@celldex.com
Charles Liles
Associate Director of Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3107
cliles@celldex.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Apr 2023 to Apr 2024